Levosalbutamol sulfate API belongs to a category of drugs known as beta-agonists. Its mechanism of action involves the relaxation and dilation of the airways in the lungs, so facilitating easier respiration. Levosalbutamol is utilized for the management of COPD (chronic obstructive pulmonary disease) and asthma. Similar to other bronchodilators, it functions by inducing relaxation of the smooth muscle in the bronchial tubes, thereby reducing or reversing a sudden episode of breathlessness or respiratory distress.